MoneyWorks4Me

Auro Laboratories - Quaterly Results

06 Feb 2024 Evaluate
The Revenue for the quarter ended  December 2023 of Rs. 179.78 millions grew by 15.07 % from Rs. 156.24 millions.The Net Profit of the company reported a remarkable increase of 649.04% to Rs. 27.34  millions  from Rs. 3.65 millions in previous same quarter.Operating profit for the quarter ended December 2023 rose to 45.03 millions as compared to 8.76 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 179.78 156.24 15.07 415.72 393.69 5.60 528.94 508.66 3.99
Other Income 4.23 4.28 -1.17 11.05 3.22 243.17 9.41 10.92 -13.83
PBIDT 45.03 8.76 414.04 93.67 23.64 296.24 53.33 57.17 -6.72
Interest 4.45 1.00 345.00 10.60 6.81 55.65 8.14 8.26 -1.45
PBDT 40.58 7.76 422.94 83.07 16.83 393.58 45.19 48.91 -7.61
Depreciation 2.70 2.70 0.00 8.10 7.70 5.19 10.74 10.17 5.60
PBT 37.88 5.06 648.62 74.97 9.13 721.14 34.45 38.74 -11.07
TAX 10.54 1.41 647.52 20.86 2.54 721.26 10.04 10.29 -2.43
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.03 -0.38 -107.89
PAT 27.34 3.65 649.04 54.11 6.59 721.09 24.41 28.45 -14.20
Equity 62.32 62.32 0.00 62.33 62.33 0.00 62.33 62.32 0.02
PBIDTM(%) 25.05 5.61 346.73 22.53 6.00 275.24 10.08 11.24 -10.29
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..